BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

Science reset – what success requires
Opinion

Peter Griffin: Science reset – what success requires

A big-picture view is needed from the prime minister's new chief science adviser.

KiwiSaver in action 2025
Opinion

David Chaplin: KiwiSaver in action 2025

More KiwiSaver members might think the funds will do something different this year.

David Chaplin 13 May 2025
It’s not the debt that’ll sink us
Opinion Economy

Dileepa Fonseka: It’s not the debt that’ll sink us

A surplus won’t fix ageing, underinvestment, or stalled reform.

Dileepa Fonseka 12 May 2025
Productivity: Uncloud the BS
Opinion

Simon Robertson: Productivity: Uncloud the BS

The goal of productivity is to simply get the most out of the least time spent.

Simon Robertson 10 May 2025